Taku Nakahara Founder of Metagen Therapeutics Backed bySMBC Venture CapitalHideaki Imaeda SourcesMetagen Therapeutics, a Microbiome Drug Discovery Company, Raises Approximately ¥2.3 Billion in Series B — 2025-09 Browse all founders · Browse investors
